Dihydralazine Sulfate/Hydrochlorothiazide/Clonidine Hydrochloride

硫酸双肼屈嗪/氢氯噻嗪/盐酸可乐定

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDihydralazine Sulfate/Hydrochlorothiazide/Clonidine Hydrochloride
Drug Alias Name复方硫酸双肼屈嗪片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAdrenergic receptors alpha-2 agonists
TargetsThiazide-sensitive sodium-chloride cotransporterAlpha-2c adrenergic receptorAlpha-2a adrenergic receptor +[5] 
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Dihydralazine SulfateHydrochlorothiazideClonidine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A